Clinical Trial Update: Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan, oxaliplatin, and capecitabine as first-line therapy for metastatic or unresectable locally advanced small bowel cancer; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Intestine Adenocarcinoma
• Small Intestine Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Irinotecan (Camptosar) (Irinotecan)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Small Intestine Adenocarcinoma, Recurrent Small Intestine Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-24